Development of Lipomer Nanoparticles for the Enhancement of Drug Release, Anti-Microbial Activity and Bioavailability of Delafloxacin

Delafloxacin (DFL) is a novel potent and broad-spectrum fluoroquinolone group of antibiotics effective against both Gram-positive and negative aerobic and anaerobic bacteria. In this study, DFL-loaded stearic acid (lipid) chitosan (polymer) hybrid nanoparticles (L-P-NPs) have been developed by singl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pharmaceutics
Autores principales: Anwer, Md. Khalid, Iqbal, Muzaffar, Muharram, Magdy M., Mohammad, Muqtader, Ezzeldin, Essam, Aldawsari, Mohammed F., Alalaiwe, Ahmed, Imam, Faisal
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7151119/
https://ncbi.nlm.nih.gov/pubmed/32168906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12030252
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares